News Releases

Filter News Releases by year:
2023 | 2022 | 2021 | 2020 | 2019

4 Results

October 2022

Three-dose hepatitis B vaccine regimen protects people with HIV

October 20, 2022

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsors the ongoing Phase 3 ACTG A5379 clinical study.

August 2022

NIH Updates Hepatitis B Strategic Research Plan

August 1, 2022

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, screening and follow-up care. The revised plan incorporates lessons from the COVID-19 pandemic and recent advances in technology.

September 2021

NIAID Scientists Find a Key to Hepatitis C Entry into Cells

September 21, 2021

Understanding Structure of HCV Proteins Could Aid in Vaccine Development

May 2019

Trial Evaluating Experimental Hepatitis C Vaccine Concludes

May 29, 2019

An experimental vaccine was not found to be effective at preventing chronic hepatitis C virus (HCV) infection in adults, NIAID-supported study reports.